Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Implementing a Specialist Integrated Haematological Malignancy Imaging Reporting Paradigm to Lymphoma Radiology Assessment Can Significantly Improve the Quality of Data for Patient Management and Clinical Research

Preethika Mahalingam, MBBS, BSc, Sunil Iyengar, MBBS, FRCPath, PhD, Dima El-Sharkawi, Bhupinder Sharma, MBBS, BSc(Hons) BM FRCR

Blood (2019) 134 (Supplement_1): 5835.

https://doi.org/10.1182/blood-2019-126155

Published: 2019

Journal Articles

Thrombosis and Anticoagulation in Malignant Superior Vena Cava Syndrome

Avi Leader, MD, Shlomit Tamir, MD, Tal Friehmann, MD, Nir Livneh, Roy Ratzon, MD, Elizabeth Dudnik, MD, Alon Rozental, MD, Orly Hamburger-Avnery, MD, Baruch Brenner, MD, Pia Raanani, Hugo ten Cate, MD PhD, Galia Spectre, MD PhD

Blood (2017) 130 (Supplement 1): 3716.

https://doi.org/10.1182/blood.V130.Suppl_1.3716.3716

Published: 2017

Journal Articles

Successful Salvage of Refractory Burkitts Lymphoma Using Maximum Intensity of the DA EPOCH-R Regimen—a Case Report

Andrew K. McMillan, FRCP, Sarah Hartley, MBBS, MRCP, Catherine Loughran, Mark Bishton, Eleanor James, Catherine Griffiths, Faith Richardson, Christopher P Fox, MBChB PhD

Blood (2017) 130 (Supplement 1): 5229.

https://doi.org/10.1182/blood.V130.Suppl_1.5229.5229

Published: 2017

Journal Articles

Characteristics and Outcomes of Lymphoblastic Lymphoma Patients - the University of Miami Experience

Juan Pablo Alderuccio, MD, Pooja Amarapurkar, MD, Jennifer R Chapman, MD, Izidore S Lossos, MD

Blood (2015) 126 (23): 5083.

https://doi.org/10.1182/blood.V126.23.5083.5083

Published: 2015

Journal Articles

Prognostic Markers in Cardiac Non-Hodgkin Lymphoma: A Retrospective Review

Max J Gordon, MD, Alexey V. Danilov, MD PhD

Blood (2015) 126 (23): 5007.

https://doi.org/10.1182/blood.V126.23.5007.5007

Published: 2015

Journal Articles

Review of Primary Mediastinal Large B Cell Lymphomas in Our Hospital

Kati Hurst, Maria Cristina Moragues Martinez, Manuel Espeso de Haro, Manuel Barrios Garcia, Ana Isabel Heiniger Mazo

Blood (2014) 124 (21): 5459.

https://doi.org/10.1182/blood.V124.21.5459.5459

Published: 2014

Journal Articles

Positive Maternal-Fetal Outcomes with Treatment of Lymphoma During Pregnancy: UT MD Anderson Cancer Center Prospective Experience

Michelle A. Fanale, MD, Chao-Ming Lai, APN, Sue A Rimes, RN, Mildred M Ramirez, MD, Fredrick B Hagemeister, MD, Nathan H Fowler, MD, Anas Younes, MD, Luis E Fayad, MD, Maria Alma Rodriguez, MD, Francesco Turturro, MD, Felipe Samaniego, MD, MPH, Jorge E Romaguera, MD, Victor A Levin, MD, Sandra B Horowitz, PharmD, Joseph E Woolery, PharmD, Andrea Milbourne, MD

Blood (2012) 120 (21): 3670.

https://doi.org/10.1182/blood.V120.21.3670.3670

Published: 2012

Journal Articles

Long-Term Outcome for De Novo Lymphoblastic Lymphoma (LL) After Frontline Therapy with Hyper-CVAD Regimen and Variants.

Deborah A. Thomas, MD, Stefan Faderl, MD, Susan O'Brien, MD, William G. Wierda, MD, PhD, Guillermo Garcia-Manero, MD, Srdan Verstovsek, MD, PhD, Marina Konopleva, MD, PhD, Tapan Kadia, MD, Steven M. Kornblau, MD, Luis Fayad, MD, Jorge Romaguera, MD, Jorge E. Cortes, MD, Hagop Kantarjian, MD

Blood (2010) 116 (21): 2831.

https://doi.org/10.1182/blood.V116.21.2831.2831

Published: 2010

Journal Articles

Sequential Dose-Dense RCHOP Followed by ICE Consolidation (MSKCC protocol 01–142) without Radiotherapy for Patients with Primary Mediastinal Large B Cell Lymphoma

Craig Moskowitz, MD, Paul A Hamlin, Jr., Jocelyn Maragulia, Jessica Meikle, Andrew D Zelenetz, MD

Blood (2010) 116 (21): 420.

https://doi.org/10.1182/blood.V116.21.420.420

Published: 2010

Journal Articles

Complications of Implantable Venous Access Devices In Patients with Sickle Cell Disease

Nirmish Shah, MD, Daniel Landi, Radhika Shah, MD, Jennifer Rothman, MD, Courtney Thornburg, MD, MS

Blood (2010) 116 (21): 1649.

https://doi.org/10.1182/blood.V116.21.1649.1649

Published: 2010

Journal Articles

Liposomal Cytarabine (DepoCyte) Is Effective and Well Tolerated In Prophylaxis of Central Nervous System (CNS) Relapse of High Risk Lymphoma Patients

Wojciech Jurczak, Justyna Dzietczenia, Beata Piatkowska-Jakubas, Marcin Sobocinski, Tomasz Ogorka, Agnieszka Giza, Grzegorz Mazur, Tomasz Wrobel, MD, PhD, Aleksander Skotnicki, MD, PhD

Blood (2010) 116 (21): 4890.

https://doi.org/10.1182/blood.V116.21.4890.4890

Published: 2010

Journal Articles

A Rare Case of Kimura's Disease with Superior Vena Cava Syndrome and Biatrial Masses

Jie Sun, Rui Li, He Huang, MD, PhD, Wanzhuo Xie, Xiaoli Zhu, Huan Qian, Zhen Wang, Shan Fu

Blood (2010) 116 (21): 5068.

https://doi.org/10.1182/blood.V116.21.5068.5068

Published: 2010

Journal Articles

Favorable Outcome for Lymphoblastic Lymphoma (LL) After Frontline Therapy with the Hyper-CVAD Regimens: An Update.

Deborah A. Thomas, MD, Stefan Faderl, MD, Susan O'Brien, MD, William G. Wierda, MD, PhD, Farhad Ravandi, MD, Guillermo Garcia-Manero, MD, Srdan Verstovsek, MD, PhD, Steven M. Kornblau, MD, Luis Fayad, MD, Jorge Cortes, MD, Hagop M. Kantarjian, MD

Blood (2009) 114 (22): 4099.

https://doi.org/10.1182/blood.V114.22.4099.4099

Published: 2009

Journal Articles

Construction of An Outpatient Erythrocytapheresis Program for Pediatric Patients with Sickle Cell Disease

Paulette Bryant, MD, Richard Parmley, MD, Christine Bolen, MD, Theresa Sunderland, MD, Robert Johnson, MD, Jennifer Weisner, PNP, Karen Nishioka, BSN, Karen Roberts, RN, Richard Towell, RN, Jodi P. Strong, MBA, Evelyn Lockhart, MD, Mark Mogul, MD

Blood (2008) 112 (11): 4067.

https://doi.org/10.1182/blood.V112.11.4067.4067

Published: 2008

Journal Articles

2008 Guidelines for the Treatment of Venous Thromboembolism in Cancer Patients: Report from the French Working Group.

Blood (2008) 112 (11): 1284.

https://doi.org/10.1182/blood.V112.11.1284.1284

Published: 2008

Journal Articles

Splenectomy in Patients with Chronic Myeloid Leukemia or Myeloproliferative Diseases: Outcomes, Complications and Prognostic Implications.

Constantine S. Tam, MBBS, Raphael E. Pollock, MD, John Manning, MD, Jorge Cortes, MD, Katherine I. Lin, MBBS BND, Deborah A. Thomas, MD, Lingsha Zhou, Hagop Kantarjian, MD, Srdan Verstovsek, MD

Blood (2007) 110 (11): 2553.

https://doi.org/10.1182/blood.V110.11.2553.2553

Published: 2007

Journal Articles

Rituximab Combined with M/VACOP-B and Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma (PMLBCL): A Prospective Italian Phase II IIL Study.

Maurizio Martelli, MD, Vittorio Stefoni, MD, Giuseppina Cabras, MD, Sergio Cortellazzo, MD, Ercole Brusamolino, MD, Alessandro Levis, MD, Barbara Botto, MD, Antonio De Vivo, MD, Fiammetta Natalino, MD, Finolezzi Erica, MD, Robert Foa, MD, Pier Luigi Zinzani, MD

Blood (2006) 108 (11): 4697.

https://doi.org/10.1182/blood.V108.11.4697.4697

Published: 2006

Journal Articles

Retrospective Analysis of Primary Mediastinal Large B-Cell Lymphoma (PMBCL) Treated with Rituximab and CHOP (R-CHOP).

Amory V. Novoselac, MD, Raghu K. Kunamneni, MD, Malgorzata McMasters, MD, Miroslav R. Radevic, MD, Randy L. Levine, MD

Blood (2004) 104 (11): 4634.

https://doi.org/10.1182/blood.V104.11.4634.4634

Published: 2004

Journal Articles

Transfer of the Multidrug Resistance Gene, MDR-1, to Hematopoietic Progenitors from a Patient with Transformed Large Cell Lymphoma, and Demonstration of In Vivo Chemotherapy Protection with Dose Escalating Chemotherapy.

Pamela S. Becker, MD, PhD, Ying Ping Yu, MD, Ann Marie Ceredona, MT, MA, William V. Walsh, MD, Judith L. O’Donnell, BS, RN, Christopher Baum, MD, Lynn Kallander, BS, Philip A. Lowry, MD, T. J. Fitzgerald, MD, Peter Westervelt, MD, PhD, F. Marc Stewart, MD

Blood (2004) 104 (11): 5278.

https://doi.org/10.1182/blood.V104.11.5278.5278

Published: 2004

Journal Articles

Primary Mediastinal Large B-Cell Lymphoma: Long Term Results with an Alternating Chemotherapy Regimen Based on High-Dose Methotrexate.

Thomas J. Fietz, MD, F. Fiedler, MD, Astrid Franke, MD, Mathias Freund, MD, Dietger W. Niederwieser, MD, Eckhard Thiel, MD, Wolfgang U. Knauf, MD, East German Study Group on Hematology and Oncology

Blood (2004) 104 (11): 3301.

https://doi.org/10.1182/blood.V104.11.3301.3301

Published: 2004

NARROW

Implementing a Specialist Integrated Haematological Malignancy Imaging Reporting Paradigm to Lymphoma Radiology Assessment Can Significantly Improve the Quality of Data for Patient Management and Clinical Research

Thrombosis and Anticoagulation in Malignant Superior Vena Cava Syndrome

Successful Salvage of Refractory Burkitts Lymphoma Using Maximum Intensity of the DA EPOCH-R Regimen—a Case Report

Characteristics and Outcomes of Lymphoblastic Lymphoma Patients - the University of Miami Experience

Prognostic Markers in Cardiac Non-Hodgkin Lymphoma: A Retrospective Review

Review of Primary Mediastinal Large B Cell Lymphomas in Our Hospital

Positive Maternal-Fetal Outcomes with Treatment of Lymphoma During Pregnancy: UT MD Anderson Cancer Center Prospective Experience

Long-Term Outcome for De Novo Lymphoblastic Lymphoma (LL) After Frontline Therapy with Hyper-CVAD Regimen and Variants.

Sequential Dose-Dense RCHOP Followed by ICE Consolidation (MSKCC protocol 01–142) without Radiotherapy for Patients with Primary Mediastinal Large B Cell Lymphoma

Complications of Implantable Venous Access Devices In Patients with Sickle Cell Disease

Liposomal Cytarabine (DepoCyte) Is Effective and Well Tolerated In Prophylaxis of Central Nervous System (CNS) Relapse of High Risk Lymphoma Patients

A Rare Case of Kimura's Disease with Superior Vena Cava Syndrome and Biatrial Masses

Favorable Outcome for Lymphoblastic Lymphoma (LL) After Frontline Therapy with the Hyper-CVAD Regimens: An Update.

Construction of An Outpatient Erythrocytapheresis Program for Pediatric Patients with Sickle Cell Disease

2008 Guidelines for the Treatment of Venous Thromboembolism in Cancer Patients: Report from the French Working Group.

Splenectomy in Patients with Chronic Myeloid Leukemia or Myeloproliferative Diseases: Outcomes, Complications and Prognostic Implications.

Rituximab Combined with M/VACOP-B and Radiotherapy in Primary Mediastinal Large B-Cell Lymphoma (PMLBCL): A Prospective Italian Phase II IIL Study.

Retrospective Analysis of Primary Mediastinal Large B-Cell Lymphoma (PMBCL) Treated with Rituximab and CHOP (R-CHOP).

Transfer of the Multidrug Resistance Gene, MDR-1, to Hematopoietic Progenitors from a Patient with Transformed Large Cell Lymphoma, and Demonstration of In Vivo Chemotherapy Protection with Dose Escalating Chemotherapy.

Primary Mediastinal Large B-Cell Lymphoma: Long Term Results with an Alternating Chemotherapy Regimen Based on High-Dose Methotrexate.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only